12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

TRV130: Phase I started

Trevena began a placebo-controlled, U.S. Phase I study to evaluate single-ascending doses of intravenous TRV130 in patients with moderate-to-severe post-operative...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >